SBIR-STTR Award

Biofeedback apparatus for home treatment of bruxism
Award last edited on: 5/17/02

Sponsored Program
SBIR
Awarding Agency
NIH : NIDCR
Total Award Amount
$49,999
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
David C Nemir

Company Information

TXL Group Inc (AKA: X-L Synergy LLC~XL Synergy~X-L Electronics Inc )

2000 Wyoming Avenue
El Paso, TX 79903
   (915) 533-7800
   sales@.xlsynergy.com
   www.xlsynergy.com
Location: Single
Congr. District: 16
County: El Paso

Phase I

Contract Number: 1R43DE009481-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1991
Phase I Amount
$49,999
The Phase I objective is to design a biofeedback apparatus for the home treatment of nocturnal bruxism and to conduct a pilot study on its effectiveness. This apparatus will consist of a bruxism sensor and radio transmitter that can be integrated into any custom dental acrylic splint. When a bruxing event is detected, a radio signal proportional to bruxing force triggers a nightstand alarm. The nightstand unit will be programmable to ignore a percentage of bruxing events, thus implementing the selectable reinforcement schedule thought necessary by leaming theorists. In addition, it will record times and frequencies of such events allowing the patient to monitor progress and the clinician to keep statistics. The goals of Phase I are to integrate a bruxism sensor and telemetry unit into a comfortable splint, to develop a receiver/alarm unit, and to carry out a pilot study on efficacy. These efforts will form the basis for a Phase II collaboration with the University of Pittsburgh Dental School to refine the device, implement clinical trials and FDA qualify a commercial instrument. As an estimated 5% of the adult population exhibit pathological bruxing, the development of an effective home treatment device should have wide commercial appeal.Awardee's statement of the potential commercial applications of the research:The device under investigation is at least as effective as the current most effective treatment for nocturnal bruxism (a night guard) but with the addition of programmable biofeedback, represents a means for the patient to monitor bruxism and learn not to brux. As there are an estimated 500,000 night guards fabricated to treat bruxism each year in the U.S., the commercial potential is considerable. Furthermore, the development of miniature, minimally invasive, low power telemetry techniques coupled with signal processing and microtransducers will have applicability to many other types of medical research.National Institute of Dental Research (NIDR)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----